- Patient raises over £1,000 for Cancerkin by cutting off her hair
- Pro bono help from Ernst and Young
- Study may have found a new method to stop breast cancer cells growing
Patient raises over £1,000 for Cancerkin by cutting off her hair
One of our patients, Laura Lantaff, is raising money for Cancerkin by cutting off her hair. Laura is about to start chemotherapy, and decided to raise money for Cancerkin by chopping off her hair before it begins to fall out. She began collecting on the 14th October and by the 17th had already raised over £1,100 – and so everyone at Cancerkin wants to say a huge congratulations and thanks to Laura!
If you would like to donate to Laura, her JustGiving page can be found here, with her full story, which is well-worth a read.
Pro bono help from Ernst and Young
On the 9th and 10th October, Victoria, Cancerkin’s CEO, and Holly, our Events and Development Manager, attended a Confidence with Clients workshop at Ernst and Young, with the aim of creating a publicity plan to encourage more women over the age of 60 to use Cancerkin’s services.
The meetings were very successful: the lively and enthusiastic Ernst and Young team came up with interesting ideas for attracting new patients which we will be implementing, including a greater use of videos for publicity and working with GP surgeries and other healthcare services to ensure everyone who could benefit from Cancerkin’s services is aware of the support we offer.
Over half the women diagnosed with breast cancer each year are over the age of 60, yet this is not represented in the proportion of older women we see at Cancerkin. Ultimately, we want to ensure our work benefits as many people as possible.
If you are reading this and you know of anyone who may be interested in our services, please do pass on our details. We welcome patients of all ages and from all locations.
Study may have found a new method to stop breast cancer cells growing
Research published in Nature Communications has discovered new proteins which breast cancer cells rely on to grow.
Scientists from the University of Newcastle looked at two proteins, Tra2β and Tra2α, which both appear in large amounts in breast cancer cells. They found that when the proteins were removed, a third protein, CHK1, could be turned off.
Chemotherapy and radiotherapy work by damaging the DNA of cancer cells, causing them to die. However, some breast cancer cells are able to recover from this damage. CHK1 helps cancer cells to repair mistakes in their chromosomes, meaning that they can continue to grow and spread to other parts of the body.
While CHK1’s role in tumour growth is well-known, this is the first study to find a link between Tra2β, Tra2α and CHK1. Now this link is known, scientists can investigate whether turning off Tra2 proteins could be a viable method of helping to stop breast cancer cells dividing and growing.
Katherine Woods, Research Communications Manager at Breast Cancer Campaign, said: “12,000 women in the UK die of breast cancer each year, the vast majority because their cancer has spread. We urgently need to find better treatments that stop all cancer cells in their tracks, and ensure that they don’t find a way to survive beyond treatment.
“The research carried out by Professor Elliott and his team has provided us with crucial knowledge about the roles that two specific proteins can play in this process, bringing us one step closer to our goal that by 2030 we will have identified what causes different tumours to grow and progress, enabling us to select the best treatment for every patient, maximising their chances of survival.”
For more information, please see Breast Cancer Campaign